Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant.
Daniëls V, Vancraenenbroeck R, Law BM, Greggio E, Lobbestael E, Gao F, De Maeyer M, Cookson MR, Harvey K, Baekelandt V, Taymans JM.
Daniëls V, et al. Among authors: taymans jm.
J Neurochem. 2011 Jan;116(2):304-15. doi: 10.1111/j.1471-4159.2010.07105.x.
J Neurochem. 2011.
PMID: 21073465
Free PMC article.